Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Ovarian Neoplasms 8Breast Neoplasms 6Neoplasm Metastasis 5Carcinoma, Non-Small-Cell Lung 5Stomach Neoplasms 3Neoplasms 3Colonic Neoplasms 3Triple Negative Breast Neoplasms 2Recurrence 2Melanoma 2Lung Neoplasms 2Solid Tumors 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Nervous System Neoplasms 1Locally Advanced Rectal Cancer 1Fallopian Tube Neoplasms 1Colorectal Neoplasms 1Central Nervous System Diseases 1Carcinoma, Hepatocellular 1Brain Neoplasms 1Brain Metastases From Non-small Cell Lung Cancer 1Brain Diseases 1Advanced Solid Tumors 1

Interventions

Sorafenib 79pembrolizumab 37Bevacizumab 36Nivolumab 33lenvatinib 30atezolizumab 24durvalumab 17Oxaliplatin 12Ipilimumab 12regorafenib 9Capecitabine 9tremelimumab 8Injections 8Doxorubicin 8tislelizumab 7sintilimab 7Fluorouracil 7cabozantinib 6budigalimab 6brivanib 6Ramucirumab 6toripalimab 5Gemcitabine 5Everolimus 5Cyclophosphamide 5ADI PEG20 5fludarabine 4Sunitinib 4Leucovorin 4E-7386 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Carcinoma, Hepatocellular × veliparib × Clear all
NCT00526617 2017-11-21

A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer Patients

AbbVie

Phase 1 Completed
41 enrolled
BreastDermatologicGastrointestinalGynecologic

Breast Neoplasms, Fallopian Tube Neoplasms, Carcinoma, Hepatocellular, Melanoma, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡